/PRNewswire/ Day Zero Diagnostics Inc., an infectious disease diagnostics company utilizing genome sequencing and machine learning to combat the rise of.
Caris Life Sciences’ massive new capital raise gives it a valuation of nearly $8 billion
The Irving-based precision medicine company is getting a major boost from an $830 million equity round.
Caris Life Sciences is headquartered in Irving.(Courtesy of Caris Life Sciences)
4:28 PM on May 11, 2021 CDT
The Irving-based precision medicine pioneer Caris Life Sciences is hauling in a massive investment that places a nearly $8 billion valuation on the 13-year-old company.
The $830 million equity round includes some of the biggest names in investment circles, including Sixth Street and funds associated with T. Rowe Price, Fidelity, Silver Lake and Coatue. A dozen other investors also took part.